Milbert Bayot is a drug safety professional currently serving as the Director of Global Patient Safety at Gilead Sciences, a position held since 2022. With extensive experience in clinical trial safety monitoring and pharmacovigilance, Milbert previously worked in various roles at Gilead Sciences from 2018 to 2022, including Associate Director and Drug Safety Specialist II. Milbert also has a background in medical surveillance and clinical safety from previous positions at Amylin Pharmaceuticals and Hollis-Eden Pharmaceuticals. Currently studying for a BS in Cell and Molecular Biology at San Diego State University, Milbert demonstrates a strong proficiency in safety reporting and clinical trial management.
This person is not in any teams
This person is not in any offices